Table 2.
Demographic characteristics of patients.
| Characteristic | Total |
HIV Positive |
HIV Negative |
|
|---|---|---|---|---|
| N = 86 | N = 12 | N = 74 | ||
| Age (median, IQR), years | 36 (28–49) | 34 (29–36) | 41 (25–49) | |
| Gender | ||||
| Male | 38 (44%) | 10 (83%) | 28 (38%) | |
| Female | 48 (56%) | 2 (17%) | 46 (62%) | |
| TST positive∗ | 25/57 (44%) | 5/6 (83%) | 20/51 (39%) | |
| Follow up duration (median, IQR), days | 153 (28–470) | 153 (30–538) | 114 (21–445) | |
| HIV positive | 12 (14%) | |||
| Laterality | ||||
| Unilateral | 47 (55%) | 5 (42%) | 42 (57%) | |
| Bilateral | 39 (45%) | 7 (58%) | 32 (43%) | |
| Location of inflammation | ||||
| Anterior uveitis | 11 (13%) | 1 (8%) | 10 (14%) | |
| Intermediate uveitis | 2 (2%) | 0 (0%) | 2 (3%) | |
| Posterior uveitis | 30 (35%) | 5 (42%) | 25 (33%) | |
| Panuveitis | 43 (50%) | 6 (50%) | 37 (50%) | |
IQR: interquartile range, TST: Tuberculin skin test, IGRA: Interferon Gamma Release Assay: tuberculosis, VKH: Vogt Koyanagi Harada, FUS: Fuchs uveitis syndrome. ∗TST positive cut-off ≥ 10 mm and ≥ 5 mm in HIV-negative and HIV-positive, respectively; 29 patients were not tested for TST: 6 HIV positive and 23 HIV negative.